CSF amyloid β 1-42 predicts cognitive decline in Parkinson's disease

被引：0
|
作者：
Siderowf, A.
Xie, S. X.
Hurtig, H. I.
Weintraub, D.
Duda, J. E.
Chen-Plotkin, A.
Shaw, L. M.
Van Deerlin, V.
Trojanowski, J. Q.
Clark, C. M.
机构：
来源：
MOVEMENT DISORDERS | 2010年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
51
引用
收藏
页码：S205 / S205
页数：1
相关论文
共 50 条
  • [1] CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease
    Siderowf, A.
    Xie, S. X.
    Hurtig, H.
    Weintraub, D.
    Duda, J.
    Chen-Plotkin, A.
    Shaw, L. M.
    Van Deerlin, V.
    Trojanowski, J. Q.
    Clark, C.
    NEUROLOGY, 2010, 75 (12) : 1055 - 1061
  • [2] CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease
    Terrelonge, Mark, Jr.
    Marder, Karen S.
    Weintraub, Daniel
    Alcalay, Roy N.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2016, 58 (01) : 88 - 92
  • [3] CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease
    Mark Terrelonge
    Karen S. Marder
    Daniel Weintraub
    Roy N. Alcalay
    Journal of Molecular Neuroscience, 2016, 58 : 88 - 92
  • [4] CSF Aβ1-42 level is associated with cognitive decline in early Parkinson's disease with rapid eye movement sleep behavior disorder
    Ba, Maowen
    Yu, Guoping
    Kong, Min
    Liang, Hui
    Yu, Ling
    TRANSLATIONAL NEURODEGENERATION, 2018, 7
  • [5] CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease
    Liu, Changqin
    Cholerton, Brenna
    Shi, Min
    Ginghina, Carmen
    Cain, Kevin C.
    Auinger, Peggy
    Zhang, Jing
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (03) : 271 - 276
  • [6] Parkinson's disease: evolution of cognitive impairment and CSF Aβ1-42 profiles in a prospective longitudinal study
    Lerche, Stefanie
    Wurster, Isabel
    Roeben, Benjamin
    Machetanz, Gerrit
    Zimmermann, Milan
    Bernhard, Felix
    Stransky, Elke
    Deuschle, Christian
    Schulte, Claudia
    Hansson, Oskar
    Zetterberg, Henrik
    Gasser, Thomas
    Berg, Daniela
    Maetzler, Walter
    Brockmann, Kathrin
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (02): : 165 - 170
  • [7] Changes in serum uric acid, glutathione, and amyloid-β1-42 levels in Parkinson's disease patients and their association with disease progression and cognitive decline
    He, Qianqian
    Zhang, Zhaoting
    Fu, Bing
    Chen, Jiechun
    Liu, Jianhua
    CURRENT MEDICAL RESEARCH AND OPINION, 2025, 41 (01) : 105 - 113
  • [8] Perivascular space in Parkinson's disease: Association with CSF amyloid/ tau and cognitive decline
    Chen, Huimin
    Wan, Huijuan
    Zhang, Meimei
    Wardlaw, Joanna M.
    Feng, Tao
    Wang, Yilong
    PARKINSONISM & RELATED DISORDERS, 2022, 95 : 70 - 76
  • [9] CSF tau and amyloid β1-42 (Aβ42) as possible biomarkers of Alzheimer disease
    Ravid, R
    Kamphorst, W
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S298 - S298
  • [10] Correlation between decreased CSF α-synuclein and Aβ1-42 in Parkinson disease
    Buddhala, Chandana
    Campbell, Meghan C.
    Perlmutter, Joel S.
    Kotzbauer, Paul T.
    NEUROBIOLOGY OF AGING, 2015, 36 (01) : 476 - 484
12345